Pulmonary Diseases

News Pulmonary Diseases

• Marine compound discovery shows promise of improved drug treatment for COPD patients

  Pharmacy researchers at the University of Florida have isolated a new marine compound they believe may lead to improved drug therapies for pulmonary diseases by inhibiting their progression rather than managing their symptoms. Known as symplostatin 5, the compound was extracted from blue-green algae more

• Inflammatory biomarkers improve the clinical prediction of mortality in COPD

  The addition of changes in inflammatory biomarkers to established clinical variables improves the prediction of mortality in patients with chronic obstructive pulmonary disease (COPD), according to a new study."COPD is characterized by low-grade inflammation, so we hypothesized that the addition of more

• Positive multi-center COPD trial with inhaled Bimosiamose

  Revotar Biopharmaceuticals AG announced that it successfully completed a multi-center Phase II trial to evaluate the safety and efficacy of inhaled Bimosiamose for the treatment of patients with chronic obstructive pulmonary disease (COPD). Data have been accepted for the annual congress of the Euro more

Publications Pulmonary Diseases

• Inhibitory effects of hesperetin derivatives on guinea pig phosphodiesterases and Their ratios between high‐ and low‐affinity rolipram binding

  Abstract The phosphodiesterase (PDE)4 molecule exists as two distinct conformers, PDE4H and PDE4L, which have high and low affinities, respectively, for the selective PDE4 inhibitor, rolipram. The inhibition of PDE4H and PDE4L is associated with adverse responses, such as nausea, vomiting, and g more

• The Coexistence of Asthma and Chronic Obstructive Pulmonary Disease (COPD): Prevalence and Risk Factors in Young, Middle-aged and Elderly People from the General Population

  by Roberto de Marco, Giancarlo Pesce, Alessandro Marcon, Simone Accordini, Leonardo Antonicelli, Massimiliano Bugiani, Lucio Casali, Marcello Ferrari, Gabriele Nicolini, Maria Grazia Panico, Pietro Pirina, Maria Elisabetta Zanolin, Isa Cerveri, Giuseppe Verlato Background The joint distribution o more

• Efficacy and safety of eco-friendly inhalers: focus on combination ipratropium bromide and albuterol in chronic obstructive pulmonary disease

  Panos RJ more

Market studies Pulmonary Diseases

• Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2012

  Introduction GlobalData's clinical trial report, “Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2012" provides data on the Obstructive Pulmonary Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Obstructive Pu more

• Chronic Obstructive Pulmonary Disease (COPD) – Pipeline Review, H2 2012

  Introduction Global Markets Direct’s, 'Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2012', provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) therapeutic pipeline. This report provides information on the therapeutic development for Chronic Obstructive Pu more

• Anesthesia and Respiratory Devices Market to 2017 - Sleep Apnea Diagnostic Systems and Portable Anesthesia Delivery Machines to be the Fastest Growing Categories

  GBI Research’s report, “Anesthesia and Respiratory Devices Market to 2017 - Sleep Apnea Diagnostic Systems and Portable Anesthesia Delivery Machines to be the Fastest Growing Categories” provides key data, information and analysis on the global anesthesia and respiratory devices market. The report p more

Websites Pulmonary Diseases